1. Home
  2. NBIX vs HMY Comparison

NBIX vs HMY Comparison

Compare NBIX & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$158.25

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Harmony Gold Mining Company Limited

HMY

Harmony Gold Mining Company Limited

HOLD

Current Price

$15.85

Market Cap

9.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
HMY
Founded
1992
1950
Country
United States
South Africa
Employees
N/A
34350
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
9.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
HMY
Price
$158.25
$15.85
Analyst Decision
Strong Buy
Buy
Analyst Count
22
2
Target Price
$180.91
$16.00
AVG Volume (30 Days)
1.2M
4.5M
Earning Date
05-05-2026
02-04-2016
Dividend Yield
N/A
2.13%
EPS Growth
41.95
N/A
EPS
1.91
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$37.43
Revenue Next Year
$13.14
$27.44
P/E Ratio
$83.53
$15.60
Revenue Growth
977.51
N/A
52 Week Low
$117.84
$13.03
52 Week High
$162.39
$26.04

Technical Indicators

Market Signals
Indicator
NBIX
HMY
Relative Strength Index (RSI) 75.63 42.54
Support Level $125.54 $14.93
Resistance Level $158.92 $16.21
Average True Range (ATR) 4.50 0.53
MACD 2.55 0.03
Stochastic Oscillator 89.50 22.70

Price Performance

Historical Comparison
NBIX
HMY

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.

Share on Social Networks: